Nevada legislation · 83rd Legislature (2025)
Nevada SB354: Revises provisions relating to health insurance coverage of prescription drugs. (BDR 57-1041)
Status: Introduced
What the bill says
An act relating to insurance; prohibiting certain health plans from requiring step therapy before providing coverage for certain prescription drugs for the prevention of human immunodeficiency virus or the treatment of human immunodeficiency virus or hepatitis C; and providing other matters properly relating thereto…
From the engrossed text, April 25, 2025:
AN ACT relating to insurance; prohibiting certain health plans from requiring step therapy before providing coverage for certain prescription drugs for the prevention of human immunodeficiency virus or the treatment of human immunodeficiency virus or hepatitis C; and providing other matters properly relating thereto. Legislative Counsel's Digest: Existing law requires certain public and private health plans, including the Public Employees' Benefits Program, to cover: (1) drugs that prevent the acquisition of human immunodeficiency virus or that treat human immunodeficiency virus or hepatitis C; (2) related laboratory and diagnostic procedures; and (3) certain other services to test for, prevent or treat human immunodeficiency virus or hepatitis C. (NRS 287.04335, 689A.0437, 689B.0312, 689C.1671, 695A.1843, 695B.1924, 695C.050, 695C.1743, 695G.1705) Existing law prohibits such health plans from implementing any medical management techniques on the coverage of such drugs or services, except the use of step therapy. (NRS 287.010, 287.04335, 689A.0437, 689B.0312, 689C.1671, 695A.1843, 695B.1924, 695C.050, 695C.1743, 695G.1705) Sections 1-7 of this bill remove the exemption for step therapy for private health plans, thereby prohibiting such health plans from requiring step therapy before providing coverage for a drug or (2) treats human immunodeficiency virus or hepatitis C. Sections 6-8.5 of this bill authorize the Public Employees' Benefits Program and Medicaid managed care - *SB354_R1* organizations to continue requiring the use of step therapy for coverage …
Sponsors
- Jeff Stone (R, 20) · primary sponsor
- James Ohrenschall (D, 21)
- Melanie Scheible (D, 9)
- Rebecca Edgeworth (R, 35)
Latest actions
- : (No further action taken.)
- : From printer. To engrossment. Engrossed. First reprint. To committee.
- : Notice of eligibility for exemption. Taken from General File. Re-referred to Committee on Finance. Exemption effective. To printer.
- : From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 315.) Reprinting dispensed with.
- : From printer. To committee.
- : Read first time. Referred to Committee on Commerce and Labor. To printer.
Common questions
- What is SB354?
- SB354 is a bill in the Nevada Legislature (83rd Legislature (2025)): Revises provisions relating to health insurance coverage of prescription drugs. (BDR 57-1041).
- What does SB354 do?
- In its own words: An act relating to insurance; prohibiting certain health plans from requiring step therapy before providing coverage for certain prescription drugs for the prevention of human immunodeficiency virus or the treatment of human immunodeficiency virus or hepatitis C; and providing other matters properly relating thereto…
- What is the status of SB354?
- Introduced. Latest action: (No further action taken.) (June 3, 2025).
- Who sponsored SB354?
- Jeff Stone (R, 20), with 3 co-sponsors.
- Where is the official record for SB354?
- On the Nevada Legislature website: https://www.leg.state.nv.us/App/NELIS/REL/83rd2025/Bill/12621/Overview
Source: official Nevada record. Tracked by Delilah, AI for legislation across all 50 states and Congress.